Skip to main content

Opioid Makers Funneled Millions to Patient Advocacy Groups

Julia Lurie Mother Jones
The groups that received pharmaceutical funding—like the US Pain Foundation and the Academy of Integrative Pain Management—in turn issued guidelines minimizing the risks of opioid addiction, lobbied to change laws aimed at curbing opioid abuse, and sought to protect doctors sued for overprescribing painkillers, according to a Senate report released Monday by Missouri Sen. Claire McCaskill (D).

Bad Science

Llewllyn Hinkes-Jones Jacobin Magazine
Not only do patents push higher prices onto consumers, they burden the research world with the increased costs of paying for the intellectual property needed to do further research . . . If anything, the neoliberal approach to academic research is a return to the privately funded, pre-tenure origins of the university system when numerous schools were simply research labs and promotional arms for private industry

The Selling of Attention Deficit Disorder

Alan Schwarz New York Times
“The numbers make it look like an epidemic. Well, it’s not. It’s preposterous,” Dr. Conners, a psychologist and professor emeritus at Duke University, said in a subsequent interview. “This is a concoction to justify the giving out of medication at unprecedented and unjustifiable levels.”
Subscribe to pharmaceutical companies